• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

CheqUp and WeightWatchers to Enhance GLP-1 Weight Loss Journeys in UK with Integrated Support

by Jasmine Pennic 05/27/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– CheqUp, one of the UK’s leading providers of GLP-1 based weight loss services, and WeightWatchers, the global leader in science-backed weight management announced a new partnership. 

– The collaboration will combine the offerings of both organizations to benefit patients in the UK seeking sustainable weight loss through GLP-1 medication coupled with comprehensive behavioural support.

A Holistic Approach to GLP-1 Supported Weight Loss

The partnership aims to deliver a seamless solution by integrating CheqUp’s human-centric approach to prescribed weight loss medication—which includes dedicated clinical support and live, one-to-one health coaching—with WeightWatchers’ science-backed GLP-1 Companion Programme. This programme provides tailored nutritional and behavioural lifestyle support specifically for individuals on GLP-1 medications. Together, these complementary offerings are designed to provide a more effective solution to weight management, helping members achieve better results than with medication alone.

This collaboration addresses the growing demand in the UK market, where an estimated 12 million people qualify for prescription GLP-1 medications. The UK Government is also currently examining the case for a wider rollout of these medications, recognizing their significant potential to improve health and impact work productivity. The CheqUp and WeightWatchers partnership offers a holistic model of care for those currently using, or considering, GLP-1 medication.

Enhanced Resources for CheqUp Members

Through this partnership, CheqUp members who pursue their weight loss journey with GLP-1 medications will now receive the following tools and resources from WeightWatchers’ GLP-1 Companion Programme, at no additional cost:

  • Nutritional guidance from experts: This includes access to GLP-1 “go-to” food recommendations designed to guide decisions towards more nutrient-dense foods that can help minimize side effects and support healthy weight loss.
  • A simple tracking experience: Members will be supported with three daily nutrition targets focusing on protein, fruits and vegetables, and hydration.
  • Judgement-free support: Access to WeightWatchers’ vibrant members-only social network groups, where individuals can connect, share nutrition and activity insights, and receive invaluable emotional support from others on a similar GLP-1 journey.
  • A comprehensive progress overview: Tools to track weight loss, identify trends, and provide a clear roadmap for future success.

“We are delighted that WeightWatchers chose CheqUp to be its strategic partner when it comes to holistic healthcare in the GLP-1 category,” said James Hunt, Deputy CEO of CheqUp. “We are seeing exponential growth in the number of people who are choosing CheqUp to help them through what is a sometimes difficult but incredibly rewarding journey of weight loss. There is no doubt that the addition of WeightWatchers’ breakthrough GLP-1 companion programme will add enormously to our patients’ ability to achieve sustainable weight loss through its science-backed and proven programmes, together with their global community of like-minded individuals. We are proud that WeightWatchers has put their trust in our human-centric approach and access to the expertise of our clinicians and Health Coaches. This partnership offers the most attractive proposition in the market for those looking to benefit from the incredible potential of GLP-1 medications and behaviour change”.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: GLP-1

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

Meaningful Use Penalties_Meaningful Use_Partial Code Free_Senators Urge CMS to Establish Clear Metrics for ICD-10 Testing

CMS Finalizes TEAM Model: A New Era of Value-Based Surgical Care

White House Event Unveils CMS Health Tech Ecosystem Initiative

White House Event Unveils CMS Health Tech Ecosystem Initiative

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low, But AI Dominates and $1B+ IPOs Emerge

Healthcare Investment Shifts in 1H 2025: AI Remains a Bright Spot Amidst Fundraising Decline

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low

Digital Health Faces Q2’25 Pullback: Funding Falls to 5-Year Low

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |